Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04973137 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis (AFFIRM-AL) |
| First Submitted : | July 1, 2021 |
| First Submitted that Met QC Criteria : | July 21, 2021 |
| First Posted : | July 22, 2021 |
| Last Update Submitted that Met QC Criteria : | March 2, 2023 |
| Last Update Posted : | March 6, 2023 |